Retirement of Anita Baldauf

27 June 2024 Retirement of Anita Baldauf AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Anita Baldauf has announced her intention not to seek re-election and to retire as a director of the company at the upcoming shareholders meeting on Friday 2nd August 2024. Chair David Flacks said: “On behalf of the Board, I would like to sincerely thank Anita for her valuable contribution and service during her four-year tenure. Her industry knowledge and international finance and marketing experience has been of great assistance to AFT particularly in its continued growth internationally.” The Board will now commence a recruitment process for a replacement director, and further details will be announced in due course. Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief Financial Officer. For more information: Investors Media Dr Hartley Atkinson Richard Inder Managing Director The Project AFT Pharmaceuticals Tel: +64 21 645 643 Tel: +64 9488 0232 About AFT Pharmaceuticals (ASX:AFP, NZX:AFT) www.aftpharm.com AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over the counter, prescription, and hospital. AFT Pharmaceutical's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs.